1 |
Stein DJ, Cameron A, Amrein R, Montgomery SA. Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder. Int. Clin. Psychopharmacol. 17: 161-170 (2002)
DOI
ScienceOn
|
2 |
Jensen PN, Moller HJ, Smith DF, Rosenberg R. Acute effect of exercise on human blood platelet serotonin uptake and monoamine oxidase activity. Biol. Psychiatry. 38: 125-127 (1995)
DOI
ScienceOn
|
3 |
: SAS User's Guide, Statistics, 6th ed. SAS Institute Inc., Cary, NC, USA (1988)
|
4 |
Sterling J, Herzig Y, Goren T, Finkelstein N, Lerner D, Goldenberg W, Miskolczi I, Molnar S, Rantal F, Tamas T, Toth G, Zagyva A, Zekany A, Lavian G, Gross A, Friedman R, Razin M, Huang W, Krais B, Chorev M, Youdim MB, Weinstock M. Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease. J. Med. Chem. 45: 5260-5279 (2002)
DOI
ScienceOn
|
5 |
Nowakowska E, Kus K, Chodera A, Rybakowski J. Investigating potential anxiolytic, antidepressant and memory enhancing activity of deprenyl. J. Physiol. Pharmacol. 52: 863-873 (2001)
PUBMED
|
6 |
Ahlskog JE. Slowing Parkinson's disease progression: recent dopamine agonist trials. Neurology 1160: 381-389 (2003)
|
7 |
McEwen CM, Cohen JR, Cohen JD. An amine oxidase in normal human serum. J. Lab. Clin. Med. 62: 766-776 (1963)
PUBMED
|
8 |
Sambamoorthi U, Olfson M, Walkup JT, Crystal S. Diffusion of new generation antidepressant treatment among elderly diagnosed with depression. Med. Care. 41: 180-194 (2003)
DOI
ScienceOn
|
9 |
Brown BR. Treating depression in the HIV-infected patient. HIV Clin. 14: 1-8 (2002)
PUBMED
|
10 |
Hwang KH, Song I. The inhibitory activity on MAO of the fruit of Morus Iba. Korean J. Pharmacogn. 34: 185-189 (2003)
|
11 |
Hwang KH, Kim IR, Han YN. Effects of cold and hot drugs on the activity of monoamine oxidase, Korean J. Pharmacogn. 30: 145-150 (1999)
|
12 |
Laux G, Philipp M, Kohnen R. Hypertension with moclobemide. Lancet. 347: 1330 (1996)
|
13 |
Silberstein SD. Migraine: preventive treatment. Curr. Med. Res. Opin. 17 (Suppl. 1): s87-93 (2001)
DOI
|
14 |
Schwartz MK, Bodansky O. Lactic acid dehydrogenase (clinical aspects). Methods in Enzymology 14: 294-302 (1969)
|
15 |
Hwang KH, Ma JY, Kim IR. The studies on the theory of KIMI by the activity of monoamine oxidase. Korean J. Herbology 14: 1-14 (1999)
|
16 |
Barhan D, Trinder P. An improved colour reagent for the determination of blood glucose by oxidase system. Analyst 97: 142-144 (1972)
DOI
ScienceOn
|
17 |
Felner AE, Waldmeier PC. Cumulative effects of irreversible MAO inhibitors in vivo. Biochem. Pharmacol. 28: 995-1002 (1979)
DOI
ScienceOn
|
18 |
Bergman J, Yasar S, Winger G. Psychomotor stimulant effects of beta-phenylethylamine in monkeys treated with MAO-B inhibitors. Psychopharmacology 159: 21-30 (2001)
DOI
PUBMED
ScienceOn
|
19 |
Daniel MB, Stuart JE. Protein Methods. Wiley-Liss, New York, NY, USA (1990)
|
20 |
Hwang KH, Ma JY, Kim IR. The studies on the theory of KIMI of symptoms by the activity of monoamine oxidase. J. Assoc. Neo Med. 3: 65-74 (1998)
|
21 |
Amador E, Dorfman LE, Wacker WEC. Serum lactic dehydrogenase: An analytical assessment of current assays. Clin. Chem. 9: 391-399 (1963)
|
22 |
Danisi F. Parkinson's disease. Therapeutic strategies to improve patient function and quality of life. Geriatrics 57: 46-50 (2002)
PUBMED
|
23 |
Cooper JR, Bloom FE, Roth RH. The Biochemical Basis of Neuropharmacology. Oxford university press. New York, NY, USA (1996)
|
24 |
Kang BS. Bonchohak 6th ed. Young Lim Sa. Seoul, Korea (2000)
|
25 |
Youdim MB, Finberg JP, Tipton KF. Monoamine oxidase. Handbook of Experimental Pharmacology 90: 119-192 (1988)
|
26 |
Hwang KH. Monoamine oxidase inhibitory activities of Korean medicinal plants classified to cold drugs by the theory of KIMI. Food Sci. Biotechnol. 12: 238-241(2003)
|